Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Mansoura University
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- investigating pulmonary sequelae of covid-19.
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.
Detailed Description
This is a observational longitudinal study investigating pulmonary sequelae of covid-19. Study site: Mansoura university hospital, chest department and post covid outpatient clinic. Elmahalla chest hospital and outpatients clinic. Time of study : Two years from September 2021 to September 2023 Target population: Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis. Sample size The study will include 100 selected cases during period from 2021 to 2023 Patients : The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.
Investigators
Tamer Awad
MD
Mansoura University
Eligibility Criteria
Inclusion Criteria
- •Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.
Exclusion Criteria
- •Hospitalized or requiring intensive care unit. Known patients with chronic lung diseases Uncontrolled comorbidities
Outcomes
Primary Outcomes
investigating pulmonary sequelae of covid-19.
Time Frame: 6 month
The selected post covid patients on the day of their clinic visit (6 months after being diagnosed covid 19